Drug Profile
Research programme: gastrointestinal disorder therapeutics - Sosei Heptares/ Jitsubo
Alternative Names: JIT 8012Latest Information Update: 28 Dec 2020
Price :
$50
*
At a glance
- Originator Heptares Therapeutics; Jitsubo
- Developer Jitsubo; Sosei Heptares
- Class Peptides
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Gastrointestinal disorders
Most Recent Events
- 28 Dec 2020 No recent reports of development identified for research development in Gastrointestinal-disorders in Japan (Parenteral)
- 28 Dec 2020 No recent reports of development identified for research development in Gastrointestinal-disorders in United Kingdom (Parenteral)
- 03 Dec 2018 Heptares Therapeutics has merged with Sosei to form Sosei Heptares